It is difficult not to become excited about stem cell therapy, and this is true for basic scientists and clinicians. The ability of bone marrow-derived progenitor cells to contribute to neoangiogenesis and
myocardial generation rapidly enthused clinicians to test the concept in patients. Cardiovascular regeneration has now evolved from a true hype to a vast basic, clinical and translational research area.
Both feet back on the ground, it is clear that the future of cardiovascular regeneration depends on critical questions, which can only be answered if scientists and clinicians join forces.

This symposium will cover both basic and translational scientific topics, but also addresses questions that are relevant to clinical cardiologists. A special emphasis is put on the relevance of physical exercise, in order to tackle cardiovascular disease. After all, prevention is better than the best cure…

The organizers of the symposium feel that the programme could be of interest to basic and translational scientists working in the field of stem cell research, cardiovascular research and atherosclerosis.
The interplay between scientists and cardiologists makes this symposium also attractive to clinicians, exercise physiologists and physical therapists, dealing with cardiovascular patients